LOWER PRICES REDUCED WITH INCREASED COMPETITION AND EFFICIENT DEVELOPMENT OF DRUGS (LOWER PRICED DRUGS) ACT

Bills and resolutions

Enact (see S. 2300), S1413 [16FE]

Letters

Provisions: Annette Guarisco, Coalition for a Competitive Pharmaceutical Market, S1422 [16FE]

———David P. Sloane, AARP, S1422 [16FE]

———Kathleen Jaeger, Generic Pharmaceutical Association, S1422 [16FE]

———Ken W. Cole, General Motors Corp., S1422 [16FE]

Remarks in Senate

Enact (S. 2300), S1420 [16FE]

Texts of

S. 2300, provisions, S1421 [16FE]